The Enterprise Value as of September 2024 (TTM) for Verve Therapeutics, Inc. (VERV) is 395.15M

According to Verve Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 395.15M. This represents a change of -47.66% compared to the average of 754.94M of the last 4 quarters.

Verve Therapeutics, Inc. (VERV) Historical Enterprise Value (quarterly & annually)

How has VERV Enterprise Value performed in the past?

The mean historical Enterprise Value of Verve Therapeutics, Inc. over the last ten years is 1.35B. The current 395.15M Enterprise Value has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), VERV's Enterprise Value was at its highest in in the June 2021 quarter at 2.50B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Verve Therapeutics, Inc. (VERV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Verve Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Verve Therapeutics, Inc. (VERV) Average Enterprise Value

How has VERV Enterprise Value performed in the past?

The current Enterprise Value of Verve Therapeutics, Inc. (VERV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Verve Therapeutics, Inc. (VERV) Enterprise Value vs. Peers

How is VERV’s Enterprise Value compared to its peers?

Verve Therapeutics, Inc.’s Enterprise Value is less than Adaptive Biotechnologies Corporation (838.17M), less than Beam Therapeutics Inc. (2.01B), greater than Caribou Biosciences, Inc. (172.45M), less than Sana Biotechnology, Inc. (945.31M), less than Intellia Therapeutics, Inc. (2.16B), greater than Editas Medicine, Inc. (289.41M), less than CRISPR Therapeutics AG (3.82B), less than Prime Medicine, Inc. (436.70M), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (1.24B), greater than Century Therapeutics, Inc. (150.89M), less than Blueprint Medicines Corporation (6.14B),

Build a custom stock screener for Verve Therapeutics, Inc. (VERV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verve Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verve Therapeutics, Inc. (VERV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verve Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.